Complementary and alternative medicine use among adults with migraines/severe headaches

Headache

Volumn 51, Issue 7, 2011, Pages 1087-1097

  Wells, Rebecca Erwin ^a   Bertisch, Suzanne M ^a   Buettner, Catherine ^a   Phillips, Russell S ^a   McCarthy, Ellen P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

complementary and alternative medicine; epidemiology; migraine; mind body medicine; prevalence studies; severe headache

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ALTERNATIVE MEDICINE; ANXIETY; ARTHRALGIA; ARTICLE; BREATHING EXERCISE; EDUCATIONAL STATUS; FEMALE; HEADACHE; HEALTH SURVEY; HUMAN; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MEDITATION; MIGRAINE; PRIORITY JOURNAL; YOGA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; COMPLEMENTARY THERAPIES; FEMALE; HEADACHE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NATIONAL INSTITUTES OF HEALTH (U.S.); QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STATISTICS AS TOPIC; UNITED STATES; YOUNG ADULT;

EID: 79960577266     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2011.01917.x     Document Type: Article

References (36)

1. Victor TW, Hu X, Campbell JC, Buse DC, Lipton RB,. Migraine prevalence by age and sex in the United States: A life-span study. Cephalalgia. 2010; 30: 1065-1072.
2. Stovner LJ, Hagen K,. Prevalence, burden, and cost of headache disorders. Curr Opin Neurol. 2006; 19: 281-285. (Pubitemid 43804684)
3. Leonardi M, Raggi A, Bussone G, D'Amico D,. Health-related quality of life, disability and severity of disease in patients with migraine attending to a specialty headache center. Headache. 2010; 50: 1576-1586.
4. Hawkins K, Wang S, Rupnow M,. Direct cost burden among insured US employees with migraine. Headache. 2008; 48: 553-563. (Pubitemid 351464682)
5. Rossi P, Di Lorenzo G, Malpezzi MG, et al,. Prevalence, pattern and predictors of use of complementary and alternative medicine (CAM) in migraine patients attending a headache clinic in Italy. Cephalalgia. 2005; 25: 493-506. (Pubitemid 40903076)
6. Barnes PM, Powell-Griner E, McFann K, Nahin RL,. Complementary and alternative medicine use among adults: United States, 2002. Adv Data. 2004; 343: 1-19.
7. Eisenberg DM, Kessler RC, Van Rompay MI, et al,. Perceptions about complementary therapies relative to conventional therapies among adults who use both: Results from a national survey. Ann Intern Med. 2001; 135: 344-351. (Pubitemid 32823241)
8. Wells RE, Phillips RS, Schachter SC, McCarthy EP,. Complementary and alternative medicine use among US adults with common neurological conditions. J Neurol. 2010; 257: 1822-1831.
9. Gaul C, Eismann R, Schmidt T, et al,. Use of complementary and alternative medicine in patients suffering from primary headache disorders. Cephalalgia. 2009; 29: 1069-1078.
10. Rossi P, Torelli P, Di Lorenzo C, et al,. Use of complementary and alternative medicine by patients with cluster headache: Results of a multi-centre headache clinic survey. Complement Ther Med. 2008; 16: 220-227. (Pubitemid 351972215)
11. von Peter S, Ting W, Scrivani S, et al,. Survey on the use of complementary and alternative medicine among patients with headache syndromes. Cephalalgia. 2002; 22: 395-400. (Pubitemid 36613290)
12. Kozak S, Gantenbein AR, Isler H, et al,. Nosology and treatment of primary headache in a Swiss headache clinic. J Headache Pain. 2005; 6: 121-127. (Pubitemid 40916526)
13. Lambert TD, Morrison KE, Edwards J, Clarke CE,. The use of complementary and alternative medicine by patients attending a UK headache clinic. Complement Ther Med. 2010; 18: 128-134.
14. Rossi P, Di Lorenzo G, Faroni J, Malpezzi MG, Cesarino F, Nappi G,. Use of complementary and alternative medicine by patients with chronic tension-type headache: Results of a headache clinic survey. Headache. 2006; 46: 622-631.
15. CDC National Center for Health Statistics National Health Interview Survey 2007 Survey Description Document. 2008. [Accessed January 8, 2009]. Available from ftp://ftp.cdc.gov/pub/Health-Statistics/NCHS/Dataset- Documentation/NHIS/2007/
16. Centers for Disease Control and Prevention's National Center for Health Statistics. 2008. [Accessed July 28, 2008]. Available from http://www.cdc.gov/ nchs/nhis.htm
17. Bertisch SM, Wee CC, Phillips RS, McCarthy EP,. Alternative mind-body therapies used by adults with medical conditions. J Psychosom Res. 2009; 66: 511-519.
18. Yeh GY, Davis RB, Phillips RS,. Use of complementary therapies in patients with cardiovascular disease. Am J Cardiol. 2006; 98: 673-680. (Pubitemid 44233469)
19. CDC National Center for Health Statistics National Health Interview Survey 2007 Imputed Family Income. 2008. [Accessed January 8, 2009]. Available from http://www.cdc.gov/NCHS/nhis/2007imputedincome.htm
20. Kushi LH, Fee RM, Folsom AR, Mink PJ, Anderson KE, Sellers TA,. Physical activity and mortality in postmenopausal women. JAMA. 1997; 277: 1287-1292. (Pubitemid 27194352)
21. Health, United States 2007. 2007. [Accessed July 14, 2009]. Available from http://www.cdc.gov/nchs/data/hus/hus07.pdf
22. Fisher P, Ward A,. Complementary medicine in Europe. BMJ. 1994; 309: 107-111. (Pubitemid 24216431)
23. Barnes PM, Bloom B, Nahin RL,. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Rep. 2008; 12: 1-23.
24. Bertisch SM, Wee CC, McCarthy EP,. Use of complementary and alternative therapies by overweight and obese adults. Obesity (Silver Spring). 2008; 16: 1610-1615. (Pubitemid 351915110)
25. Wober C, Wober-Bingol C,. Triggers of migraine and tension-type headache. Handb Clin Neurol. 2010; 97: 161-172.
26. Dusek JA, Benson H,. Mind-body medicine: A model of the comparative clinical impact of the acute stress and relaxation responses. Minn Med. 2009; 92: 47-50.
27. Wahbeh H, Elsas SM, Oken BS,. Mind-body interventions: Applications in neurology. Neurology. 2008; 70: 2321-2328.
28. Campbell JK, Penzien DB, Wall EM,. Evidence-based guidelines for migraine headache: behavioral and physical treatments. US Headache Consortium 2000. 2000. [Accessed July 14, 2009]. Available from http://www.aan.com
29. Goslin RE, Gray RN, McCrory DC, Penzien D, Rains J, Hasselblad V,. Behavioral and Physical Treatments for Migraine Headache. Rockville, MD: Research AfHCPa; 1999.
30. Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR,. Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev. 2009;(1): CD001218.
31. Sandor PS, Di Clemente L, Coppola G, et al,. Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial. Neurology. 2005; 64: 713-715. (Pubitemid 40261904)
32. Diener HC, Pfaffenrath V, Schnitker J, Friede M, Henneicke-von Zepelin HH,. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention - a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia. 2005; 25: 1031-1041. (Pubitemid 41532108)
33. Lipton RB, Gobel H, Einhaupl KM, Wilks K, Mauskop A,. Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology. 2004; 63: 2240-2244. (Pubitemid 40024330)
34. Astin JA,. Why patients use alternative medicine: Results of a national study. JAMA. 1998; 279: 1548-1553. (Pubitemid 28233010)
35. Bonetto N, Santelli L, Battistin L, Cagnin A,. Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum. Cephalalgia. 2007; 27: 1421-1423. (Pubitemid 350150799)
36. Evans RW, Tepper SJ, Shapiro RE, Sun-Edelstein C, Tietjen GE,. The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper. Headache. 2010; 50: 1089-1099.